This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citing articles on HighWire  • Citing articles on Web of Science (26)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

John P. Valentic, MD; Ronald J. Barr, MD; Gerald D. Weinstein, MD

Arch Dermatol. 1983;119(10):871-872.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

Isotretinoin is extremely effective in the treatment of severe cystic acne.^1,2 We have recently noted the occurrence of inflammatory neovascular nodules

See also p 808. (INNs), or exuberant nodular granulation tissue, in two of 12 patients with severe acne who were treated with oral isotretinoin.

Report of Cases

Case 1.—

A 17-year-old boy with severe acne was entered into the Hoffmann-La Roche Isotretinoin Study. His acne had progressed while he was receiving conventional topical, intralesional, and oral therapy all of which were discontinued several weeks prior to entry into the study. Physical examination of the patient revealed numerous, crusted, draining, inflammatory nodulocystic lesions associated with sinus tracts, pustules, comedones, and mild scarring involving the face, neck, upper aspect of the trunk, and proximal, upper part of the arms. According to the study protocol, the patient began receiving a moderately low dose (1 mg/kg/day) of oral isotretinoin, which was increased . . . [Full Text PDF of this Article]

Author Affiliations
From the Department of Dermatology, University of California at Irvine.

Footnotes
Reprints not available.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?